Predictive modeling of aspirin‐triggered resolvin D1 pharmacokinetics for the study of Sjögren's syndrome
Abstract Objectives Sjögren's syndrome (SS) is an autoimmune disease that causes chronic inflammation of the salivary glands leading to secretory dysfunction. Previous studies demonstrated that aspirin‐triggered resolvin D1 (AT‐RvD1) reduces inflammation and restores tissue integrity in saliva...
Saved in:
Main Authors: | Venkata Kashyap Yellepeddi (Author), Olga J. Baker (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predicting Resolvin D1 Pharmacokinetics in Humans with Physiologically‐Based Pharmacokinetic Modeling
by: Venkata K. Yellepeddi, et al.
Published: (2021) -
Aspirin-triggered resolvin D1 reduces parasitic cardiac load by decreasing inflammation in a murine model of early chronic Chagas disease.
by: Ileana Carrillo, et al.
Published: (2021) -
Aspirin-triggered Resolvin D1 ameliorates activation of the NLRP3 inflammasome via induction of autophagy in a rat model of neuropathic pain
by: Yi-Hao Wang, et al.
Published: (2023) -
Predicting Maternal and Infant Tetrahydrocannabinol Exposure in Lactating Cannabis Users: A Physiologically Based Pharmacokinetic Modeling Approach
by: Babajide Shenkoya, et al.
Published: (2023) -
Mast cells contribute to the resolution of allergic inflammation by releasing resolvin D1
by: Pier Giorgio Puzzovio, et al.
Published: (2023)